Data / Form D filings / Chimeron Bio Corp
Chimeron Bio Corp: Form D filings
Chimeron Bio Corp, a biotechnology company in Philadelphia, PA, filed 5 Form D notices with the SEC between 2020 and 2025. The latest, on March 14, 2025, reports $12.8 million sold of an offering with no set size to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 WALNUT STREET, SUITE 715, Philadelphia, PA, 19106
- Phone
- (267) 343-1117
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1837360
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Amendment | Indefinite | $12,811,690 | 9 | Mar 25, 2024 | sec.gov | |
| Mar 3, 2025 | New notice | Indefinite | $13,736,689 | 9 | Mar 25, 2024 | sec.gov | |
| Nov 30, 2022 | New notice | $10,000,000 | $1,200,000 | $8,800,000 | 3 | Oct 31, 2022 | sec.gov |
| Mar 10, 2022 | New notice | $3,000,000 | $782,000 | $2,218,000 | 1 | Feb 28, 2022 | sec.gov |
| Dec 28, 2020 | New notice | $5,000,000 | $300,000 | $4,700,000 | 2 | Dec 9, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Antonin de Fougerolles | Director | |
| Monica Coleman | Executive Officer | |
| Kevin Heyeck | Executive Officer, Director | |
| Afshin Safavi | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Mar 10, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Chimeron Bio Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.